Title: Liver-directed strategies and immunologic consequences of recombinant AAV-mediated cross-correction of glycogen storage disease type II
Description: <a href="http://uf.catalog.fcla.edu/uf.jsp?st=UF003087838&ix=pm&I=0&V=D&pm=1" rel="nofollow"> http://uf.catalog.fcla.edu/uf.jsp?st=UF003087838&ix=pm&I=0&V=D&pm=1</a>
Subjects: DNA, Recombinant--physiology, DNA, Recombinant--therapeutic use, alpha-Glucosidases--physiology, alpha-Glucosidases--secretion, Glycogen Storage Disease Type II--prevention